Tome Biosciences

Tome Biosciences is a programmable gene insertion company. Using CRISPR, Tome Biosciences' technology enables the company to insert any gene sequence of any size at any location into any genome. Tome Biosciences is writing the final chapter of genomic medicine by providing treatments for patients through cellular and genomic engineering.